Healthcare AI News 7/10/24

News

OpenAI co-founder and CEO Sam Altman and Thrive Global founder and CEO Arianna Huffington announce that their companies will co-develop an AI-powered, hyper-personalized app for behavior change, which they say can be a “miracle drug” for preventing disease and optimizing health. Thrive AI Health will learn preferences and patterns related to sleep, food, movement, stress, and social connection and will be trained on the user’s biometric, lab, and other medical data. Some of the new company’s concepts are already being used by Thrive Global, which sells its product to employers.

Health wearables vendor Oura releases the AI-powered Oura Advisor, which it calls a personal wellness coach, for testing with its devices. Users can choose the chatbot’s communication style, notification preferences, and the training goals that it emphasizes.

A radiation oncologist creates prior authorization requests by telling ChatGPT the type of letter that he needs and the types of clinical studies that he could cite to support his request. He then tells ChatGPT to make the resulting letter four times longer because “if you’re going to put all kinds of barriers up for my patients, them when I fire back, I’m going to make it very time consuming.” A rehab medicine physician uses Doximity GPT, a HIPAA-compliant version of the chatbot, to analyze EHR data and coverage details to create a detailed request, which is says has boosted his coverage approval rate from 10% to 90%. The article notes that some Epic users are testing its new AI-powered PA functionality.

Business

South Korea-based AIRS Medical, whose FDA-cleared SwiftMR speeds up MRI scanning time by up to 50%, raises $20 million in a Series C funding round.

Amazon Web Services uses a large language model to design marketing content for disease awareness that it says balances accuracy and audience engagement. The company says that the AI assistant reduces creation time from weeks to hours and gives subject matter experts more control with its ability to create automatic revisions based on user instructions and comments. It also highlights any problems with required rules or regulations.

Research

Researchers survey oncologists about their possible use of AI, with these conclusions:

• They will use AI to make clinical decisions only if they as frontline practitioners can understand its logic.
• Most oncologists think that they should protect patients from biased AI tools, but few of them believe that they can recognize that bias.
• More than 90% of oncologists believe that AI developers should be held accountable if their products are involved in medical or legal problems, about double the number who believe that doctors and hospitals should share accountability.
• A medical oncologist predicts that AI tools will be used in three areas: making treatment decisions using a broader set of data, improving tumor characterization from images, and matching patients with clinical trials.

Boston researchers apply an AI model to demographic data, health history, exam results, neurological tests, and MRI scans to identify 10 distinct causes of dementia to support differential diagnosis.

Scientists at Dana-Farber Cancer Center and Weill Cornell Medicine develop digital pathology AI tools that can answer pathologist questions and compile results. They trained a private, secure Dana-Farber version of ChatGPT on 10,000 pages of recent digital pathology developments, which allows researchers to create detailed, summarized results quickly. They also developed a tool to allow pathologists who don’t program in the Python programming language to use the PathML computational pathology analysis tool.

Other

A philanthropy magazine profiles the $20 million donation to Mayo Clinic for AI work by Dwight Diercks, an engineering SVP and employee #22 at Nvidia, who grew up on a family farm in rural Minnesota. The focus of his donation is early cancer diagnosis.

Contacts

Mr. H, Lorre, Jenn, Dr. Jayne.
Get HIStalk updates.
Send news or rumors.
Contact us.